Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (32)
Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man
1978 • 612 citations
Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients
1978 • 364 citations
An Angiotensin Converting-Enzyme Inhibitor to Identify and Treat Vasoconstrictor and Volume Factors in Hypertensive Patients
1974 • 349 citations
ALDOSTERONE SECRETION AND PRIMARY AND MALIGNANT HYPERTENSION *
1960 • 308 citations
IMMUNE-COMPLEX GLOMERULOPATHY IN PATIENTS TREATED WITH CAPTOPRIL
1980 • 305 citations
Antihypertensive action of propranolol
1973 • 256 citations
Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme
1977 • 246 citations
Converting enzyme inhibition with an orally active compound in hypertensive man.
1979 • 224 citations
LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSION
1979 • 191 citations
Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.
1979 • 185 citations
Renin Release during Acute Reduction of Arterial Pressure in Normotensive Subjects and Patients with Renovascular Hypertension*
1967 • 181 citations
Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man.
1976 • 165 citations
Plasma Renin Concentration in Human Hypertension. 1: Relationship Between Renin, Sodium, and Potassium
1965 • 146 citations
Proteinuria During Long-term Captopril Therapy
1980 • 101 citations
Blindness after treatment for malignant hypertension.
1979 • 99 citations
Hydralazine and Plasma Renin Activity
1968 • 79 citations
Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.
1979 • 78 citations
Reactive Hyperreninemia in Renovascular Hypertension After Angiotensin Blockade with Saralasin or Converting Enzyme Inhibitor
1979 • 76 citations
Clinical use of an orally acting converting enzyme inhibitor: captopril.
1980 • 74 citations
Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.
1979 • 73 citations
Hypertensive Emergencies
1974 • 71 citations
TREATMENT OF HYPERTENSION WITH PROPRANOLOL AND HYDRALAZINE
1971 • 68 citations
Disparate Patterns of Aldosterone Response During Diuretic Treatment of Hypertension
1977 • 59 citations
Use of First-Dose Response or Plasma Renin Activity to Predict the Long-Term Effect of Captopril
1980 • 54 citations
Low-Renin Hypertension
1974 • 43 citations
A Role for Renin in Rebound Hypertension and Encephalopathy after Infusion of Saralasin Acetate (Sar1-Ala8-Angiotensin II)
1976 • 41 citations
Management of severe hypertension
1973 • 38 citations
Converting Enzyme Inhibition in Hypertensive Emergencies
1979 • 35 citations
Acute and chronic effect of captropril in hypertensive patients.
1980 • 28 citations
Minoxidil Therapy in Refractory Hypertension Analysis of 155 Patients
1978 • 27 citations
Reactive Hyper-Reninaemia to Angiotensin Blockade Identifies Renovascular Hypertension
1979 • 27 citations
Current Treatment of Malignant Hypertension
1975 • 10 citations